Latest News - Zimmer Biomet
Top Corporates Hub
Zimmer Biomet
Zimmer Biomet Holdings (ZBH) Names Asia Pacific Chief, Is The 8% Discount Enough?
15.07.2026 00:22
Zimmer Biomet Holdings (ZBH) drew investor attention after appointing Chintan Desai as president of its Asia Pacific region, a key geography for the medical technology company’s global footprint and long term plans. See our latest analysis for Zimmer Biomet Holdings. The executive change comes as Zimmer Biomet Holdings trades at US$91.03, with a 7 day share price return of 1.81% and a 30 day share price return of 2.78%, while the 1 year total shareholder return has declined 2.17% and the 3...
These S&P500 stocks are moving in today's session
14.07.2026 16:35
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
ISRG Stock: What Does Its Valuation Imply?
14.07.2026 12:52
This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
14.07.2026 11:00
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chintan Desai has been named president of the company's Asia Pacific Region, effective immediately.
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
13.07.2026 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
BMO Capital Initiates Coverage of Zimmer Biomet Holdings (ZBH) with Market Perform Recommendation
11.07.2026 01:32
Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity
02.07.2026 04:29
Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement includes a collaboration between the companies to advance the iovera spasticity program. The transaction is expected to close in the third quarter of 2026, subject to customary conditions. Zimmer Biomet operates as a large medical device company with a core focus on orthopedics and related surgical solutions. The planned addition of the iovera device extends its reach...
Pixee Medical Names Kristoff Goson CEO, Signaling Major Push for U.S. Market Growth
29.06.2026 15:00
CAMBRIDGE, Mass., June 29, 2026--Today, Pixee Medical announced the appointment of American healthcare executive Kristoff Goson as new Chief Executive Officer. A former senior executive at Zimmer Biomet, Goson will lead the company’s U.S. commercial expansion and global growth strategy as demand increases for more accessible and simplified surgical guidance technologies.
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
24.06.2026 15:24
ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.
Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates
11.06.2026 00:19
Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
26.05.2026 12:09
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
18.05.2026 13:40
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
18.05.2026 13:14
Abbott vs. Zimmer Biomet: surgical equipment stocks face diverging growth, acquisitions, and valuation shifts as investors weigh momentum and margins.
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
18.05.2026 12:30
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Orthopedic Soft Tissue Repair Market size & share revenue was valued at approximately USD 7.26 Billion in 2025 and is expected to reach USD 7.96 Billion in 2026 and is expected to reach around USD 15.38 Billion by 2035, at a CAGR of 9.6 between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Arthrex Inc., Stryke
Why Zimmer Biomet (ZBH) Stock Is Up Today
16.05.2026 03:00
Shares of medical device company Zimmer Biomet (NYSE:ZBH) jumped 4.9% in the afternoon session after the company announced it increased its share repurchase expectations for fiscal year 2026.
Zimmer Biomet (ZBH) Valuation Check After Announcing Expanded US$1b Share Repurchase Plan
15.05.2026 04:37
Zimmer Biomet Holdings (ZBH) has drawn fresh attention after announcing plans to repurchase up to US$1b of its common stock in fiscal 2026, representing a US$250m increase under its existing authorization. See our latest analysis for Zimmer Biomet Holdings. Despite the enlarged 2026 repurchase plans and upcoming appearance at the Bank of America Global Healthcare Conference, the stock’s recent momentum has been weak, with the 30 day share price return down 14.37% and the 1 year total...
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
12.05.2026 10:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.
Zimmer Biomet Increases Its 2026 Share Buyback Target By $250M To $1B
12.05.2026 06:37
All repurchases are expected to be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Zimmer Biomet Board of Directors and announced in February 2026. The company has
Investors Can Find Comfort In Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Quality
11.05.2026 10:32
The most recent earnings report from Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) was disappointing for shareholders...
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
06.05.2026 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m. PT (11:40 a.m. ET).